C3is Inc. financial data

Symbol
CISS on Nasdaq
Location
331 Kifissias Avenue, Erithrea, Athens, Greece
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Apr 28, 2025

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 924K shares -91%
Common Stock, Value, Issued 9.24K USD -91%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 676K USD -97.9%
Inventory, Net 1.14M USD +2.96%
Other Assets, Current 27.9K USD -71.6%
Assets, Current 9.2M USD -81.6%
Property, Plant and Equipment, Net 80.9M USD -7.44%
Assets 90.1M USD -34.4%
Accrued Liabilities, Current 1.22M USD +39.3%
Liabilities, Current 5.71M USD -89.9%
Liabilities 15.5M USD -78.2%
Retained Earnings (Accumulated Deficit) 650K USD
Stockholders' Equity Attributable to Parent 74.6M USD +12.5%
Liabilities and Equity 90.1M USD -34.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 924K shares -91%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 676K USD -97.9%
Property, Plant and Equipment, Gross 95M USD 0%
Operating Lease, Liability, Current 58.5K USD -2.14%
Preferred Stock, Shares Authorized 200M shares 0%
Additional Paid in Capital 73.9M USD +7.03%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%